Company Filing History:
Years Active: 2017
Title: Andrew L MacKinnon: Innovator in Cancer Treatment
Introduction
Andrew L MacKinnon is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of cancer treatment through his innovative research and development.
Latest Patents
Andrew holds a patent for a groundbreaking invention titled "Combination therapy with glutaminase inhibitors." This invention relates to methods of treating cancer, myeloproliferative diseases, or immunological or neurological diseases. It utilizes a combination of a glutaminase inhibitor and an anticancer agent, which may include an enzyme inhibitor, a mitotic inhibitor, a DNA-modifying agent, or a cytidine analog. Furthermore, the invention addresses methods for treating diseases that are resistant to one or more anticancer agents. He has 1 patent to his name.
Career Highlights
Andrew is currently employed at Calithera Biosciences, Inc., where he continues to advance his research in the medical field. His work focuses on developing effective therapies for challenging diseases.
Collaborations
Some of Andrew's coworkers include Susanne M Steggerda and Mirna L Rodriguez, who contribute to the collaborative efforts in their research endeavors.
Conclusion
Andrew L MacKinnon is a dedicated inventor whose work in combination therapies is paving the way for new treatments in oncology and related fields. His contributions are vital to the ongoing fight against cancer and other serious diseases.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.